...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Will there be an anniversary gift?

Tomorrow marks the one year mark since first dosing in the single agent ZEN-3694 trial. Will we get an anniversary gift?

BearDownAZ

Share
New Message
Please login to post a reply